Treatment of Mild to Moderate Pulmonary Blastomycosis in a Child (Under 18)
When acute pulmonary blastomycosis presents with mild to moderate severity in a pediatric patient, the patient's age is a defining factor in selecting the appropriate treatment strategy. Management in children under 18 follows a specific protocol that differs from adult recommendations.
Mild to moderate pulmonary blastomycosis in a child under 18 years of age. The pediatric age group drives both agent selection and the overall approach to therapy.
An oral antifungal agent is recommended for children in this category. The specific drug, weight-based dosing parameters, and treatment duration are defined in the full protocol.
References
DOI: 10.1086/588300
For children with mild to moderate infection, oral itraconazole, at a dosage of 10 mg/kg per day to a maximum of 400 mg per day for 6–12 months, is recommended (B-III).
View source ↗